Abstract
Introduction

1
Depression is among the most common mental illnesses worldwide and 2 accounts for 5.5% of all years lost through disability globally 1 to stressful life events and early-life traumas [3] [4] [5] [6] . In turn, reported trauma exposure 8 has been robustly correlated with a range of adverse life outcomes including MDD 6-9 9 . The relationship between MDD and reported trauma exposure is complex, with 10 studies showing both that reported trauma exposure is associated with subsequent 11 MDD, and that MDD is associated with subsequent reported trauma exposure 10,11 . 12 However, the majority of people reporting exposure to traumatic experiences do not 13 report MDD [6] [7] [8] [9] . 14 Twin studies show that MDD is moderately heritable, with 30-40% of the 15 variance in MDD attributable to genetic factors 12 . The proportion of heritability 16 captured by common genetic variants, also known as single nucleotide 17 polymorphism or SNP-based heritability, can be estimated from genome-wide 18 association study (GWAS) data. Such estimates tend to be lower than those 19 obtained from twin approaches, due to the incomplete capture of genetic information 20 in GWAS data among other reasons 13 . The most recent major depression GWAS 21 from the Psychiatric Genomics Consortium was anchored in 35 cohorts (including 22 the 23andMe discovery cohort 14 ) recruited with a variety of methods 15 . This meta- 23 analysis identified 44 loci significantly associated with major depression, and 24 estimated a SNP-based heritability of 9-10% 15 . GWAS results strongly suggest both 25 the mild and more severe forms of depression are polygenic, with potentially 1 thousands of variants with very small individual effects contributing to risk. 2 There are far fewer genetic studies of reported trauma exposure than of MDD. 3 However, the available studies have demonstrated that reported trauma exposure is 4 heritable, with twin heritability estimates of 20-50% [16] [17] [18] and SNP-based heritability 5 estimates of 30% 19 . Combining measures of trauma exposure and depression on a 6 large scale is difficult and, as with many environmental measures, requires careful 7 phenotyping 20 . Potential confounds include the (often unavoidable) use of 8 retrospective self-reported measures of trauma exposure, which can be weakly 9 correlated with objective measures of traumatic experiences 9 . Furthermore, current 10 (i.e. state) low mood or MDD can increase self-reporting of previous trauma 11 exposure 9, 21 . Previous individual study cohorts have generally been too small for 12 effective GWAS, while meta-analyses have contained considerable heterogeneity 13 due to the use of different phenotyping instruments in the included studies. 14 However, some notable genome-wide analyses of MDD and trauma exposure 15 have been performed. A genome-wide by environment interaction study of 16 depressive symptoms and stressful life events in 7,179 African American women 17 identified a genome-wide association near the CEP350 gene (although this did not 18 replicate in a smaller cohort) 22 . A recent investigation in 9,599 Han Chinese women 19 with severe MDD identified three variants associated with MDD specifically in 20 individuals who did not report exposure to traumatic events prior to MDD onset 23 . 21 Several attempts have been made to estimate the interaction of overall 22 genetic risk and trauma by using polygenic risk scores for MDD to perform polygenic ; significant multiplicative interactions only 25 ; and, in the largest previous study 4 published (a meta-analysis of 5,765 individuals), no interactions 26 . 5 Studies of gene-environment interaction usually assume the genetic and 6 environmental influences are independent and uncorrelated 27 . However, genetic 7 correlations between reported trauma exposure and MDD have been reported, both 8 from twin studies [28] [29] [30] and from the genomic literature 22, 26 . Reports of the magnitude 9 of this genetic correlation have varied widely, which reflects differences in defining 10 trauma exposure, and in the populations studied. While some studies have identified 11 a very high genetic correlation (95%) 22 , others have found no such correlation 23 .
12
The relationship between reported trauma exposure and MDD, and the influence of 13 genetic variation on that relationship, is therefore complex and unresolved. equivalent to removing up third-degree relatives and closer 41 ) or whose phenotypic 15 and genotypic gender information was discordant (X-chromosome homozygosity (F X ) 16 < 0.9 for phenotypic males, F X > 0.5 for phenotypic females) were also excluded. 17 Removal of relatives was performed using a "greedy" algorithm, which minimises 18 exclusions (for example, by excluding the child in a mother-father-child trio). All 19 analyses were limited to individuals of European ancestry, as defined by 4-means 20 clustering on the first two genetic principal components provided by the UK Biobank 21 42 . This ancestry group included 95% of the respondents to the mental health 22 questionnaire -as such, the non-European ancestry groups were considered too 23 small to analyse informatively. Principal components analysis was also performed on 24 the European-only subset of the data using the software flashpca2 43 SNP-based heritability 7 Results from GWAS were combined to assess the proportion of variance due 8 to the additive effect of common genetic variants (SNP-based heritability). SNP-9 based heritability was calculated on the observed scale using BOLT-LMM v2.3 49 .
10
The estimate for MDD in the cohort was converted to the liability scale in R 3. and reported trauma exposure differs from the product of their individual effects. 13 Multiplicative interactions were tested using logistic regression 25, 26 . A significant 14 additive interaction means that the combined effect of the risk score and reported 15 trauma exposure differs from the sum of their individual effects. Additive interactions 16 were tested using linear regression (Supplementary Methods). Table 6 ; Supplementary Figures 1-3) . No analysis showed evidence 4 of genome-wide inflation that was attributable to confounding (95% confidence   5 intervals of all regression intercepts from LD Score included 1; Supplementary Table   6 7). One genome-wide significant locus (rs11515172, Chr 9:11Mb, p = 3.82x10 -8 ) was 7 identified in the analysis of MDD overall, and remained significant when using logistic small difference in expected SNP-based heritability for those reporting and not 10 reporting trauma is in the opposite direction to our findings. This suggests that our 11 findings cannot be explained by genetic correlation between MDD and reported 12 trauma exposure, nor by the transformation from the observed scale to the liability 13 scale. 14 
15
Genetic correlations 16 Genetic correlations were calculated between MDD and reported trauma to 17 explore the genetic relationship between these traits. Further genetic correlations 18 were calculated between MDD in the two strata to assess whether genetics 19 influences on MDD differ in the context of reported trauma exposure (Supplementary   20   Table 10 ). 21 We observed a significant r g between MDD and reported trauma exposure in Polygenic risk scores across strata 1 2 We performed polygenic risk score analyses to further explore how 3 stratification by trauma status affects the genetic relationship between MDD and 4 specific correlates of MDD, and to mirror previous analyses in the literature ( Figure   5 2, Table 2; see Supplementary Table 12 for full details of all risk score analyses, 6 including the number of SNPs in each score) 26 . Individuals with high genetic risk 7 scores for MDD were more likely to be cases than controls, and a significant additive 8 interaction term was observed from linear regression. Specifically, the combined 9 effect of the MDD risk score and reported trauma exposure on MDD was greater 10 than the sum of the individual effects (beta > 0, Table 2 reporting trauma exposure (SNP-h 2 = 12%), as described above. 15 In contrast, although those with higher BMI risk scores were more likely to be 16 cases than controls, this only passed correction for multiple testing in individuals 17 reporting trauma exposure. Both the additive (beta > 0) and the multiplicative (OR > 18 0) interaction terms were significant, suggesting the combined effect on MDD from 19 BMI risk score and reported trauma exposure together was greater than expected 20 from both the sum of the individual risks and from their product, respectively (OR > 21 1). 22 Individuals with high genetic risk scores for SCZ were more likely to be cases 23 than controls, but this did not differ between strata (both interaction terms p >0.01).
24
Individuals with higher BIP risk scores were also more likely to be cases than 25 controls -although this association was not significant in the subset of individuals 26 reporting trauma exposure, no significant interaction term was observed, suggesting 1 the observed difference in results within-strata may be due to differences in power. 2 No significant differences were observed in the negative control analysis with HbA1c. Table 2 : Main effect and interaction effects for polygenic risk scores (PRS) associated with MDD overall and in stratified analyses. Interaction effects are on the additive scale (Beta) and the multiplicative scale (OR). Bold = significant associations (main analyses: p < 0.000143; interactions: p < 0.01). Base N = Cases // Controls. OR/Beta = Increase with 1 SD increase in risk score or trauma exposure. Results are reported at the "best" threshold (that with the lowest p-value in main effect analyses) -results across all thresholds are reported in Supplementary Table 12 .
Sensitivity analyses 1 Four sets of sensitivity analyses were performed. In the first set, all analyses 2 were repeated using reported trauma exposure as the phenotype, assessed overall 3 and stratified by MDD (as opposed to the primary analysis, where MDD was the 4 phenotype and analyses were stratified by reported trauma exposure). Results from 5 these analyses were broadly similar to the results from the primary analysis 6 (Supplementary Tables 3-12 , Supplementary Figures 4-7) . 7 The second set of sensitivity analyses repeated the primary analyses with main analysis likely result from BMI differences between MDD cases and controls, 21 rather than being true effects on MDD. 22 The third set of sensitivity analyses repeated the genetic correlation analyses, Childhood Experiences (ACEs). This literature has found that such adversities are 5 associated not only with psychiatric risk but also with wide-ranging impairments in 6 social and health outcomes including obesity and education [81] [82] [83] [84] . However, we 7 stress that causal conclusions cannot be drawn from these data, or that the reported 8 trauma exposure is responsible for the observed differences. 9 Our estimate of the SNP-based heritability of MDD (20%) is higher than that 10 reported in previous studies of major depression (~9%) 15 . This may be explained by 11 the relative homogeneity of the UK Biobank compared to previous meta-analyses.
12
The UK Biobank is a single-country cohort ascertained using a consistent protocol. 13 The same questionnaire was used to gather symptom data, and the samples were 14 stored, extracted, and genotyped using a single method. In contrast, meta-analyses 15 have needed to combine diverse ascertainment, sampling, and genotyping; SNP- 16 based heritability has been reported to decrease with increasing numbers of meta- . This may also explain the genetic correlations we observe 5 with reported trauma exposure (including in controls, who do not report previous 6 psychiatric illness). 7 8 In summary, we find that genetic associations with MDD in UK Biobank vary 9 by context. Specifically, the SNP-based heritability of MDD is larger in individuals 10 reporting trauma exposure compared to those not doing so. Furthermore, the genetic 11 correlation of MDD with waist circumference was significant only in individuals 12 reporting exposure to trauma. Nonetheless, a strong genetic correlation was 13 observed between MDD measured in the two strata. Together, these findings 14 suggest the relative contribution of genetic variants to variance in MDD is greater 15 when additional risk factors are present. 16 
17
Acknowledgements
18
We thank the members of the UK Biobank Mental Health Genetics Group for 19 their valuable discussion and feedback on this work. We are also deeply indebted to 20 the scientists involved in the construction of the UK Biobank, and to the investigators 21 who comprise the PGC. Finally, we thank the hundreds of thousands of subjects who 22 have shared their life experiences with investigators in the UK Biobank and the PGC. 23 This research has been conducted using the UK Biobank Resource, as an 24 approved extension to application 16577 (Dr Breen). This study represents The PGC has received major funding from the US National Institute of Mental Health 10 and the US National Institute of Drug Abuse (U01 MH109528 and U01 MH1095320).
